Korean Medication Algorithm Project for Bipolar Disorder 2022: Mixed Features

Won Kim, Won-Myong Bahk, Young Sup Woo, Jong-Hyun Jeong, Jeong Seok Seo, IL Han Choo, Chan-Mo Yang, Jung Goo Lee, Se-Hoon Shim, Bo-Hyun Yoon, Sung-Yong Park, InKi Sohn (+3 others)
2022 Journal of Korean Neuropsychiatric Association  
Objectives Treatment guidelines or an algorithm can help clinicians implement better practices and clinical decisions. Therefore, the Korean Medication Algorithm Project for Bipolar Disorder 2022 (KMAP-BP 2022) was revised again through a consensus of expert opinion. The diagnosis and treatment of mixed features are not simple, and there are many things to discuss. We describe the preferences and recommendations from KMAP-BP 2022 for the treatment of mood episodes with mixed features. Methods
more » ... revised the KMAP-BP 2018 questionnaire and conducted the survey with expert clinicians. Out of ninety-three members of the review committee, eighty-seven completed the survey. We analyzed the answers, discussed the data, and held a clinician hearing. Results In first-step strategies for mixed features with more manic symptoms, a combination of a mood stabilizer and an atypical antipsychotic is the treatment of choice. Mood stabilizer
doi:10.4306/jknpa.2022.61.2.133 fatcat:lzcikomsfjf45crfjgcsvll7lu